Asston Pharmaceuticals IPO GMP & Review: Apply or Avoid?

Asston Pharmaceuticals IPO is open for bidding on 9th July 2025. It is a bookbuilding IPO of 22.41 lakh shares and entirely a fresh issue of worth ₹27.56 crores. The issue will be listed on BSE and SME on its tentative listing date, 16th July 2025. 

Asston Pharmaceuticals IPO Details 

The Asston Pharmaceuticals IPO date is fixed between 9th July 2025 and 11th July 2025. The face value of Asston Pharmaceuticals Limited shares stands at ₹10 per share, and the IPO price band is set between ₹115 and ₹123 per share. 

Maashitla Securities Private Limited is the registrar of the Asston Pharmaceuticals IPO and is responsible for managing the allotment process and initiating refunds. Check out the latest IPO details in the table below. 

Asston Pharmaceuticals IPO Share Reservation

Asston Pharmaceuticals IPO is a bookbuilding IPO issue of 22.41 lakh shares worth ₹27.56 crores. Asston Pharmaceuticals Limited shares will be listed on the BSE and SME. Furthermore, SEBI has specified the share reservation criteria for different investor categories. 

Asston Pharmaceuticals IPO GMP Grey Market Premium

GMP is the gap between the price band of the issue and the price at which company shares are currently trading in the grey market. Do you want to get live updates on the Asston Pharmaceuticals IPO? If yes, then you’ve reached the right spot. Check the table below to learn about the GMP trends.

As of 8th July 2025, Asston Pharmaceuticals IPO GMP stands at ₹10 per share, which means the share will likely show a listing at ₹133 (123+10) on its tentative listing date, 16th July 2025.

GMP data is subject to change based on market trends and sentiments. You should check the live GMP status before applying for the Asston Pharmaceuticals IPO. Stay informed with Univest to know about real-time insights on IPOs and their GMP trends. 

Asston Pharmaceuticals IPO Review

Check out the detailed Asston Pharmaceuticals IPO review for a thorough understanding of its potential to report listing gains on 16th July 2025. The Asston Pharmaceuticals IPO review below will help you invest effectively to avoid significant losses. Explore more to make informed investment decisions on this IPO. 

Financial Health

Assess a company’s financial performance to know about its ability to sustain a competitive edge. Thus, it is essential to understand the growth margins and declines of the business’s financials before applying for the Asston Pharmaceuticals IPO.

Asston Pharmaceuticals Limited’s revenue soared by 61.67% from ₹15.84 crores in March 2024 to ₹25.61 crores in March 2025. Moreover, the company’s PAT increased by 218.38% from ₹1.36 crores to ₹4.33 crores.

Asston Pharmaceuticals Limited has shown consistent revenue growth, indicating that the company is financially stable. Moreover, the brokers, investors, and RAs have a positive outlook for the Asston Pharmaceuticals IPO for its tentative listing day, which is 16th July 2025.  

Technical Analysis

A number of technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technicals of the Asston Pharmaceuticals IPO.

The PE ratio of Asston Pharmaceuticals Limited shares is 17.83, and its Earnings Per Share (EPS) stands at 6.90. Thus, the Asston Pharmaceuticals IPO can potentially deliver gains on its tentative listing date, 16th July 2025. 

Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Asston Pharmaceuticals Limited are subject to change after the IPO. Explore the table below to get post-issue updates on these two metrics. 

Asston Pharmaceuticals Limited Peer Comparison

Asston Pharmaceuticals IPO Subscription Status

Asston Pharmaceuticals IPO is to be opened for bidding on 9th July 2025. The subscription status for this IPO is yet to be announced. Stay informed on this passage to check the live Asston Pharmaceuticals IPO Subscription Status. 

About Asston Pharmaceuticals Limited

Asston Pharmaceuticals Limited was incorporated in 2019 and is engaged in the business of pharmaceutical products. It offers different products such as tablets, capsules, sachets, syrups, etc. Asston Pharmaceuticals Limited manufactures for direct sales and is a contract manufacturing company working on a principal-to-principal approach with multiple marketers. Here are the major competitive strengths of Asston Pharmaceuticals Limited. 

• Formulation Expertise
• Diversified Product Portfolio
• Strategic Location
• Skilled Workforce
• Experienced Promoters

Asston Pharmaceuticals Limited Financials

The company’s financial analysis is essential before applying for the Asston Pharmaceuticals IPO. Look at the table to learn about Asston Pharmaceuticals Limited’s financials. 

Explanation

Asston Pharmaceuticals Limited’s revenue soared by 61.67% from ₹15.84 crores in March 2024 to ₹25.61 crores in March 2025. Moreover, the company’s PAT increased by 218.38% from ₹1.36 crores to ₹4.33 crores. 

Asston Pharmaceuticals IPO Bidding Requirements

Asston Pharmaceuticals IPO has reserved lot sizes to be applied by different investor categories. Look at the table below to know about the requirements to be fulfilled for applying for this IPO. 

Use the lot size calculator to find how many shares you should apply!

Asston Pharmaceuticals IPO Promoter Holdings

Have a look at the table below to check the holdings of Asston Pharmaceuticals Limited’s promoters: Dr. Ashish Narayan Saklakar, Saili Jayaram More, and Sachin Chandrakant Badakh.

Note: Promoter Holdings’ value is to be calculated using Equity dilution, which represents the gap between shareholdings before and after the Issue. 

Aim of Asston Pharmaceuticals IPO

The primary aim of the Asston Pharmaceuticals IPO is to raise ₹27.56 crores. On the other hand, Asston Pharmaceuticals Limited has decided to utilise these funds in different prospects. Explore some of the secondary objectives for the Asston Pharmaceuticals IPO.

• To meet capital expenditure on the acquisition of machinery in the manufacturing facility.
• To meet the general corporate purposes.
• To fund the incremental working capital requirements of the company.
• To repay certain borrowings. 

Should I Invest in Asston Pharmaceuticals IPO?

“APL is engaged in manufacturing and exporting pharmaceutical formulations and nutraceutical products. It caters to various domestic and global customers with tailor made products. It also engaged third party contract manufacturers for certain critical products. The company posted growth in its top and bottom lines for the reported periods. However, sudden boost in bottom lines from FY25 onwards raise eyebrows and concern over its sustainability. It is operating in a highly competitive and fragmented segment. Small equity base post-IPO indicates longer gestation period for migration. Well-informed/cash surplus investors may park moderate fund for long term.”~Dilip Davda (Chief Editor at Chittorgarh)

Explore the pros and cons of the Asston Pharmaceuticals IPO to know whether you should apply or avoid the issue. These pros and cons might help you know about the IPO’s efficiency in delivering profits in the coming decades. 

Pros of Asston Pharmaceuticals IPO

• Formulation Expertise
• Experienced Promoters

Cons of Asston Pharmaceuticals IPO

• Low Market Capitalisation

How to Apply for Asston Pharmaceuticals IPO?

Check the steps mentioned below to apply for the Asston Pharmaceuticals IPO. 

• Step 1: Conduct thorough research on the Asston Pharmaceuticals IPO GMP, subscription status, issue size, lot size, and other details. 
• Step 2: Open a demat account on Univest to learn about real-time insights on GMP and subscription status. You can also use your previous demat account by navigating to the IPO section. 
• Step 3: Make a bid for 2 lots of 2,000 shares worth ₹2,46,000 of the Asston Pharmaceuticals IPO.   
• Step 4: You will receive a mandate request after making a bid. Approve the request to proceed further.    

Note: You can apply for the Asston Pharmaceuticals IPO from more than one demat account to increase your allotment chances. 

How to Check Asston Pharmaceuticals IPO Allotment Status?

You can check for the Asston Pharmaceuticals IPO allotment in different ways. These include BSE and the registrar portal. Look at the steps mentioned below to check your allotment status online.

Check On BSE

• Visit the BSE Official Website.
• Navigate to the IPO Allotment Section. 
• Select Equity as the issue type. 
• Choose the Asston Pharmaceuticals IPO.  
• Choose whether to proceed with the PAN number or the application number.
• Submit your details to get the allotment status online. 

Check On the Registrar Portal

• Visit the registrar portal. 
• Click on the allotment option.
• Fill in the required details.
• Click on the submit button to know your Asston Pharmaceuticals IPO allotment status.

Let’s Wrap

Asston Pharmaceuticals IPO is a bookbuilding issue of 22.41 lakh shares worth ₹27.56 crores. The shares of Asston Pharmaceuticals Limited will be listed on BSE and SME on its tentative listing date of 16th July 2025. Researching the Asston Pharmaceuticals IPO GMP and reviews is highly suggested to book your ideal profitability. Brokers and investors have highlighted their pros and cons, so one must analyse them and decide accordingly.

Open a demat account on Univest now to initiate your investment journey!

Also Read : Meta Infotech IPO GMP & Review: Apply or Avoid?

FAQs on Asston Pharmaceuticals IPO

How is the Asston Pharmaceuticals IPO?

Ans. Currently, on 8th July 2025, the Asston Pharmaceuticals IPO GMP (Grey Market Premium) stands at ₹10 (8.13% up). It indicates that the estimated listing price could be ₹133 per share. It is a bookbuilding IPO of 22.41 lakh shares and entirely a fresh issue worth ₹27.56 crores. The face value of each share of Asston Pharmaceuticals Limited is ₹10. 

What is the Asston Pharmaceuticals IPO price?

Ans. The Asston Pharmaceuticals IPO price band has been set between ₹115 and ₹123 per share. Retail investors can apply for a minimum of 2 lots consisting of 2,000 shares worth ₹1,46,000. Moreover, HNIs are required to bid for a minimum of 3 lots (3,000 shares) worth ₹3,69,000. 

Is the Asston Pharmaceuticals IPO good?

Ans. Asston Pharmaceuticals Limited’s revenue soared by 61.67% from ₹15.84 crores in March 2024 to ₹25.61 crores in March 2025. Moreover, the company’s PAT increased by 218.38% from ₹1.36 crores to ₹4.33 crores. Investors can analyse other relevant factors and make a decision accordingly.

Who is the registrar of the Asston Pharmaceuticals IPO?

Ans. Maashitla Securities Private Limited is the registrar of the Asston Pharmaceuticals IPO, awaiting to manage the IPO allotment procedure and refund initiation. For any queries regarding the Asston Pharmaceuticals IPO allotment and refund, you can contact Maashitla Securities Private Limited at investor.ipo@maashitla.com or +91-11-45121795-96. 

What is the issue size of the Asston Pharmaceuticals IPO? 

Ans. Asston Pharmaceuticals IPO is a bookbuilding IPO for 22.41 lakh shares worth ₹27.56 crore. Moreover, the IPO is set to open on 9th July 2025 and will be closed on 11th July 2025. 

Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Asston Pharmaceuticals IPO, download the Asston Pharmaceuticals IPO RHP and Asston Pharmaceuticals IPO DRHP. Conduct your own research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.

Also Read : Smarten Power Systems IPO GMP & Review: Apply or Avoid?

Current & Previous IPOs

Read Our Articles on the Best Stocks

Tech Stocks in India to Invest in 2025 | Tech Sector Stocks 

Best Battery Stocks in India to Invest in 2025 | Battery Sector Stocks 

Best Shipping Stocks in India to Invest in 2025 | Shipping Sector Stocks 

Paint Stocks in India to Invest in 2025 | Paint Sector Stocks 

Paper Stocks in India to Invest in 2025 | Paper Sector Stocks 

Best Semiconductor Stocks in India 2025 

Best Large Cap Stocks in India 2025 

Green Energy Penny Stocks

Best Cement Stocks To Invest in India

Also Explore

Univest Screeners

Explore Webstories on Univest 

1. Best Time To Buy Dividend Stocks

2. How RBI Policies Affect Dividend Stocks

3. Can Dividend Stocks Beat Inflation

4. What Is The Dividend Aristocrat List

5. Which Indian Psus Offer The Best Dividends

6. Large Cap Vs Small Cap Dividend Stocks